Alnylam Pharmace. buy Needham & Company LLC
Summary
This prediction is currently active. With a performance of -6.75%, the BUY prediction for Alnylam Pharmace. by Needham___Company_LL is down slightly. This prediction currently runs until 02.08.25. The prediction end date can be changed by Needham___Company_LL at any time. Needham___Company_LL has 50% into this predictionAlnylam Pharmaceuticals, Inc. (ALNY) is a biopharmaceutical company focused on the development of RNA interference (RNAi) therapeutics. Its lead drug, ONPATTRO®, is approved by the U.S. FDA for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis. The company is also developing additional RNAi therapeutic candidates for the treatment of a range of diseases, including cancer, cardiovascular disease, and viral infections. With a market capitalization of over $15 billion, Alnylam is one of the largest biotech companies in the world.
Performance without dividends (%)
Name | 1w | 1m |
---|---|---|
Alnylam Pharmace. | -6.395% | -6.395% |
iShares Core DAX® | -3.429% | 3.133% |
iShares Nasdaq 100 | -6.121% | -1.433% |
iShares Nikkei 225® | -7.364% | 1.018% |
iShares S&P 500 | -4.366% | 0.247% |
Comments by Needham___Company_LL for this prediction
In the thread Alnylam Pharmace. diskutieren
Stopped prediction by Needham___Company_LL for Alnylam Pharmace.
Alnylam Pharmace.
24.06.24
24.06.25
06.09.24
Alnylam Pharmace.
02.05.24
02.05.25
06.09.24
Alnylam Pharmace.
15.02.24
15.02.25
06.09.24
Alnylam Pharmace.
09.10.23
09.10.24
06.09.24
Alnylam Pharmace.
12.09.23
12.09.24
06.09.24
Alnylam Pharmace.
04.08.23
04.08.24
05.08.24